Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.

Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

The research, published in the Journal of Clinical Oncology, found the average time to treatment for serious muscle-invasive bladder cancer fell from 98 days to 53 days. Prof Bryan estimates the ...

A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

Shiva Rajkumar, who last month underwent bladder cancer surgery in the US, is back in his hometown of Bengaluru, where he met with fans and colleagues who were extremely happy to see him healthy.

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Incorporating mpMRI into initial staging before TURBT reduces the time to correct treatment for patients with MIBC.

With a new potential drug target for bladder cancer therapy identified, the scientists found that a combination of the statin simvastatin and a PIN1 inhibitor called sulfopin helped stop bladder ...